Skip to main content
Caplight Logo









Krokos Bio

Krokos Bio

Private
Davis, CaliforniaHealthcare & Life Scienceshttps://krokos.bio/

Last Round

Grant

Aug 19, 2025

Total Funding Raised

$305,000

Company Overview

Krokos Bio is a biotechnology company that develops plant cell culture technology to produce high-value botanical ingredients, starting with lab-grown saffron.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clean Manufacturing, Sustainable Materials

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

plant cell culturelab-grown saffroncellular agriculturecultivated ingredientsbotanical ingredientsbioreactorfood-grade ingredientsclean manufacturingsustainable ingredientsalternative sourcingprecision fermentationagtechfood tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Krokos Bio Comparables

Compare Krokos Bio with similar companies based on industry and business-model similarity.

Krokos Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Spicy Cells
91%
Novella Innovative Technology
86%
Chi Botanic
86%

Krokos Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 19, 2025
AcceleratorJul 15, 2025

Key People

Founding team and executive leadership

Jacob Lang

Founder & CEO

Founding Team

Krokos Bio Investors

Notable investors and investment history

Krokos Bio investors
InvestorRounds
Big Idea VenturesAccelerator
National Science FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 19, 2025

    $305K grant from the National Science Foundation.

  • Jul 15, 2025

    Led by Big Idea Ventures

Recent news

Latest coverage and updates

  • recognized_asSep 7, 2026

    Krokos Bio Inc. recognized as top pitch of 10 companies at fifth annual Pitch Elk Grove contest on Aug 31st '26.

Krokos Bio Filings

Explore SEC and related filing metadata, where available.

Krokos Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Krokos Bio's valuation, stock price, and market status.

Is Krokos Bio a public or private company?

Krokos Bio is a private company.

What is the current stock price of Krokos Bio?

Krokos Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Krokos Bio worth (valuation)?

Valuation information for Krokos Bio is not publicly available.

Can I buy Krokos Bio stock?

Krokos Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Krokos Bio's last funding round?

Krokos Bio's most recent funding round was Grant on August 19, 2025.

Who are the main investors in Krokos Bio?

Key investors in Krokos Bio include Big Idea Ventures.

Will Krokos Bio IPO soon?

No public IPO plans have been announced for Krokos Bio.

How can I track Krokos Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Krokos Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDavis, California
Employee Range4
Year Founded2024
Last FundingAug 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?